CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors.

Sabrina Castellano, Giorgio Stefancich, Rino Ragno, Katarzyna Schewe, Marisabella Santoriello, Antonia Caroli, Rolf W Hartmann, Gianluca Sbardella

文献索引：Bioorg. Med. Chem. 16(18) , 8349-58, (2008)

全文：HTML全文

摘要

Several derivatives out of a series of antifungal agents exhibited a good inhibitory potency against aromatase as well as a fairly good selectivity toward CYP17, even if lacking H-bond accepting substituents. Their common structural feature is a flexible backbone that did not fit into previously reported CYP19 models. Thus, a ligand-based approach was exploited to develop a novel statistically robust, self-consistent and predictive 3D-QSAR model herein proposed as a helpful tool to design new aromatase inhibitors.